arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Annexon, Inc.

ANNX
$5.39 ▼ -0.21 (-3.75%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
8 Visible periods
21 Metrics
Peer-ranked Benchmarks
Price Chart
24
Health
Poor
Bearish
auto_awesome

Analytical Summary

Annexon, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $836.0M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -102.2%
FCF / Share $-1.20
Trailing P/E
Price / Book 3.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-206.69M
↓ -49.6%
FCF / Share Free cash flow per share
$-1.20
↓ -40.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
9
Cash Quality
60

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters